Middle East and Africa Alpha-Glucosidase Inhibitors Market Size (2024 - 2029)

MEA Alpha-Glucosidase Inhibitors Market Analysis

The Middle-East and Africa Alpha-Glucosidase Inhibitors Market size is estimated at USD 57.37 million in current year, and is expected to reach USD 68.46 million by forecast year, growing at a CAGR of 3.60% during the forecast period.

COVID-19 and diabetes have a significant impact on public health in the Middle East and Africa, as well as elsewhere. Diabetes has been linked to an increased risk of fatal infections and severe infections in COVID-19 patients. Because diabetes is one of the most common health problems in the Middle East and Africa, the current study focused on understanding the epidemiology of COVID-19 in diabetics and the strategies put in place by governments to mitigate its impact. In light of the importance and necessity of the epidemic, countries in the Middle East and Africa have implemented a number of preventative and control measures.

The Middle East and African region have witnessed an alarming increase in the prevalence of diabetes, in recent years, the rate of diabetes is at an all-time high, mainly due to lifestyle changes. Diabetes is associated with many health complications. Patients with diabetes require many corrections throughout the day to maintain nominal blood glucose levels, such as administering additional insulin or ingesting additional carbohydrates by monitoring their blood glucose levels. Over the past few decades, african countries have witnessed a rapid increase in diabetes patients, especially those with type 2 diabetes. Developing countries have more than 70% of the global diabetes population. The africans anticipated to experience considerable growth due to a more geriatric population and rising prevalence of diabetes mainly due to the enhanced stress level, sedentary lifestyles, smoking, and excessive consumption of alcohol that elevates the body's sugar levels have led to the growth of the market.

This is driving the demand for Alpha-Glucosidase Inhibitors Market in Middle-East and Africa, thereby driving the market in focus during the forecast period.

MEA Alpha-Glucosidase Inhibitors Industry Segmentation

Inhibitors of alpha-glucosidase prevent the small intestine from absorbing carbohydrates. They compete with one another to prevent the enzymes that change complicated, non-absorptive carbohydrates into simple, absorbable ones. The glucoamylase, sucrase, maltase, and isomaltase enzymes are among them. The Middle East and Africa alpha-glucosidase inhibitors market is segmented by geography (Iran, Saudi Arabia, Egypt, Oman, South Africa, and the rest of the Middle East and Africa). The report offers the value (in USD) and volume (in units) for the above segments. We will provide a segment-wise breakdown (value and volume) for all the countries covered under the table of contents.